The Use of Microblog "Weibo" by Chinese Patent Medicine Companies in China

被引:2
|
作者
Song, Qirui [1 ]
Ung, Carolina Oi Lam [1 ]
Tang, Daisheng [2 ]
Hu, Hao [1 ]
机构
[1] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Taipa, Macao, Peoples R China
[2] Beijing Jiaotong Univ, Sch Econ & Management, Beijing, Peoples R China
关键词
traditional Chinese medicine; Chinese patent medicine; social media; microblog; Weibo; China; SOCIAL MEDIA; TROUBLE SPOTS;
D O I
10.1177/2168479018798799
中图分类号
R-058 [];
学科分类号
摘要
Background: In order to introduce regulatory measures to regulate social media use by the Chinese patent medicine (CPM) companies, it needs better understanding of CPM companies' promotional activities using social media. Thus, this study aimed to analyze the nature of the information conveyed to the public by the CPM companies through microblog (Weibo) in China. Methods: The content of 17 CPM Weibo accounts was analyzed. These accounts were established by 13 CPM companies, each of which had more than 10,000 followers, over 1000 posts and updated posts in 2016. Results: Of the 40,798 original posts identified in the 17 Weibo accounts, 98.39% (n = 40,142) were classified into 6 main themes: (1) social living (36%); (2) health science (26%); (3) health maintenance (14%); (4) direct product promotion (11%); (5) corporate branding (7%); and (6) medical and industrial information (6%). Among the posts directly related to product promotion, more than half (n = 2550) focused on customer interactions followed by product efficacy (n = 945). Among the posts about corporate branding, about half of them (n = 1,443) focused on company image. Conclusions: Weibo is being used by CPM companies widely for strategic product promotion. With one of the key strategies being overt marketing driven by covert marketing, a large amount of health-related information is disseminated through this platform. Regulatory policies to ensure the credibility of information disseminated in the social media used by the CPM companies for promotion purposes are warranted to help protect the public's interests.
引用
收藏
页码:490 / 496
页数:7
相关论文
共 50 条
  • [1] The Use of Microblog “Weibo” by Chinese Patent Medicine Companies in China
    Qirui Song
    Carolina Oi Lam Ung
    Daisheng Tang
    Hao Hu
    Therapeutic Innovation & Regulatory Science, 2019, 53 : 490 - 496
  • [2] Chinese Tobacco Industry Promotional Activity on the Microblog Weibo
    Wang, Fan
    Zheng, Pinpin
    Yang, Dongyun
    Freeman, Becky
    Fu, Hua
    Chapman, Simon
    PLOS ONE, 2014, 9 (06):
  • [3] EXTERNAL USE OF CHINESE PATENT MEDICINE
    Li, Yan
    Song, Yagang
    Miao, Mingsan
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 80 (01) : 15 - 15
  • [4] Spatiotemporal Analysis of Residents in Shanghai by Utilizing Chinese Microblog Weibo Data
    Hou, Li
    Liu, Qi
    Uddin, Mueen
    Khattak, Hizbullah
    Asshad, Muhammad
    MOBILE INFORMATION SYSTEMS, 2021, 2021
  • [5] User influence and microblog marketing: a case study of Sina Weibo in China
    Wang, Xiaoguang
    Gao, Yijun
    Lu, Zhuoyao
    LIBRARY HI TECH, 2023,
  • [6] The Lexicon of Fear: Chinese Internet Control Practice in Sina Weibo Microblog Censorship
    Vuori, Juha Antero
    Paltemaa, Lauri
    SURVEILLANCE & SOCIETY, 2015, 13 (3-4) : 400 - 421
  • [7] "Born in Rome"or "Sleeping Beauty": Emergence of hashtag popularity on the Chinese microblog Sina Weibo
    Cui, Hao
    Kertesz, Janos
    PHYSICA A-STATISTICAL MECHANICS AND ITS APPLICATIONS, 2023, 619
  • [8] A Retrospective Study on the Use of Chinese Patent Medicine in 24 Medical Institutions for COVID-19 in China
    Zhang, Nan
    Shi, Nannan
    Li, Siyu
    Liu, Guoxiu
    Han, Yonglong
    Liu, Li
    Zhang, Xin
    Kong, Xiangwen
    Zhang, Bihua
    Yuan, Wenpeng
    Liu, Yi
    Deng, Deqiang
    Zheng, Minxia
    Zhang, Ying
    Li, Lihua
    Wang, Xiaoping
    Wu, Jiankun
    Lin, Xiaolan
    Nian, Hua
    Wu, Xiaohong
    Wang, Hua
    Liu, Fang
    Wang, Hongli
    Wang, Hongshun
    Liu, Ying
    Zeng, Weixin
    Yang, Manqin
    Wang, Yanping
    Zhai, Huaqiang
    Wang, Yongyan
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [9] Clinical practice guidelines of Chinese patent medicine in China: A critical review
    Wang, Jian-xin
    Sun, Rui
    Si, Dong-xu
    Guo, Man-ping
    Zhang, Lijing
    Sun, Yuan-yuan
    Gao, Xue-min
    Gao, Rui
    COMPLEMENTARY THERAPIES IN MEDICINE, 2024, 85
  • [10] Prescribing Chinese patent medicines without traditional Chinese medicine training is now banned in China
    不详
    TRADITIONAL MEDICINE RESEARCH, 2019, 4 (05): : 222 - 223